Pharmaniaga hopes for better performance from Indonesia


Pharmaniaga is poised to fulfil its obligation to supply 12 million Sinovac vaccine doses to the Federal Government in three months (by June or July)

KUALA LUMPUR: Pharmaniaga Bhd hopes Indonesia's measures to curb the Covid-19 pandemic would mitigate the negative impact on the company’s operations in the country and its overall performance in the current financial year 2021 (FY2021).

Chief financial officer Norai'ni Mohamed Ali said the Indonesian government has imposed stringent control measures since the second half of 2019.

Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In Business News

Ringgit opens marginally lower against greenback as investors await 1Q GDP release
Bursa Malaysia rally to pause for profit-taking
ZTE spearheads Malaysia's 5G revolution with its ‘Unfolding the Intelligent Future 2024’ event and receives the Malaysia Book of Records’ fastest 5G-Advanced live trial award.
Trading ideas: IJM, TNB, AirAsia, Thong Guan, Seremban Engineering, UEM Sunrise
XL Axiata-Smartfren merger to yield synergy
Smart Asia IPO oversubscribed by 37.98 times
Aluminum rally is ‘overdone’ as supply returns
S P Setia posts strong 1Q profit
IRB fails in bid to get RM1.8bil taxes from TNB
IJM Land’s latest London deal poised for success

Others Also Read